Status: Recruiting
Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD
Compare the safety and efficacy of two different oral vapendavir doses with placebo in order to determine the appropriate dose of vapendavir to reduce the severity and/or duration of respiratory symptoms associated with RV infections in patients with COPD.
Participants needed: 180
Trial details
Phase: Phase 2Age: 40-85Biological sex: AllType: InterventionalSponsor: Altesa Biosciences, Inc.Updated: Jun 24, 2026Locations: 14
Eligibility criteria
Increase frequency or dose of beta agonist(s), oxygen, breathing treatments or c... [+5]